LONDON (Reuters) - U.S. drugmaker Bristol-Myers Squibb said on Tuesday it had stopped "certain initiatives" in China, when asked by Reuters to comment on industry chatter it was curbing financial incentives for prescribing doctors.
http://ift.tt/1LOJD4r
from Reuters: Health News
via animenewspro
Aucun commentaire:
Enregistrer un commentaire